Leiden Jeffrey M's Form 4 filing
Vertex Pharmaceuticals Inc (VRTX) · filed Dec 5, 2025
- Accession no.
- 0000875320-25-000242
- Filed
- Dec 5, 2025
- Trade date
- Dec 3-4, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 14 non-derivative transactions and 2 derivative transactions. Open-market sales total $28.7M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Leiden Jeffrey MCIK 0001242825 | Director, Officer (Executive Chairman) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 3, 2025 | Common Stock | MOption exerciseAcquired | +63,781 | $86.52 | +$5,518,332.12 | 87,807 | Direct | |
| Dec 3, 2025 | Common Stock | SSaleDisposed | −4,469 | $440.40F2,F3 | −$1,968,147.6 | 83,338 | Direct | |
| Dec 3, 2025 | Common Stock | SSaleDisposed | −1,320 | $441.26F2,F4 | −$582,463.2 | 82,018 | Direct | |
| Dec 3, 2025 | Common Stock | SSaleDisposed | −2,469 | $443.21F2,F5 | −$1,094,285.49 | 79,549 | Direct | |
| Dec 3, 2025 | Common Stock | SSaleDisposed | −4,352 | $444.36F2,F6 | −$1,933,854.72 | 75,197 | Direct | |
| Dec 3, 2025 | Common Stock | SSaleDisposed | −7,899 | $445.56F2,F7 | −$3,519,478.44 | 67,298 | Direct | |
| Dec 3, 2025 | Common Stock | SSaleDisposed | −1,152 | $447.05F2,F8 | −$515,001.6 | 66,146 | Direct | |
| Dec 3, 2025 | Common Stock | SSaleDisposed | −2,320 | $448.78F2,F9 | −$1,041,169.6 | 63,826 | Direct | |
| Dec 3, 2025 | Common Stock | SSaleDisposed | −5,880 | $449.84F2,F10 | −$2,645,059.2 | 57,946 | Direct | |
| Dec 3, 2025 | Common Stock | SSaleDisposed | −5,809 | $451.20F2,F11 | −$2,621,020.8 | 52,137 | Direct | |
| Dec 3, 2025 | Common Stock | SSaleDisposed | −15,681 | $452.20F2,F12 | −$7,090,948.2 | 36,456 | Direct | |
| Dec 3, 2025 | Common Stock | SSaleDisposed | −10,360 | $453.34F2,F13 | −$4,696,602.4 | 26,096 | Direct | |
| Dec 3, 2025 | Common Stock | SSaleDisposed | −2,070 | $455.22F2,F14 | −$942,305.4 | 24,026 | Direct | |
| Dec 4, 2025 | Common Stock | MOption exerciseAcquired | +1 | $91.05 | +$91.05 | 24,027 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 3, 2025 | Common Stock | MOption exerciseDisposed | −63,781 | $0.00 | $0 | 0 | Direct | |
| Dec 4, 2025 | Common Stock | MOption exerciseDisposed | −1 | $0.00 | $0 | 0 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
Dr. Leiden undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Referenced by the price of 12 transactions in Table I.
- F3
Open market sales reported on this line occurred at a weighted average price of $440.40 (range $440.04 to $441.00).
Referenced by the price of 1 transaction in Table I.
- F4
Open market sales reported on this line occurred at a weighted average price of $441.26 (range $441.14 to $442.00).
Referenced by the price of 1 transaction in Table I.
- F5
Open market sales reported on this line occurred at a weighted average price of $443.21 (range $442.94 to $443.93).
Referenced by the price of 1 transaction in Table I.
- F6
Open market sales reported on this line occurred at a weighted average price of $444.36 (range $444.00 to $444.94).
Referenced by the price of 1 transaction in Table I.
- F7
Open market sales reported on this line occurred at a weighted average price of $445.56 (range $445.00 to $445.82).
Referenced by the price of 1 transaction in Table I.
- F8
Open market sales reported on this line occurred at a weighted average price of $447.05 (range $447.00 to $447.23).
Referenced by the price of 1 transaction in Table I.
- F9
Open market sales reported on this line occurred at a weighted average price of $448.78 (range $448.18 to $449.12).
Referenced by the price of 1 transaction in Table I.
- F10
Open market sales reported on this line occurred at a weighted average price of $449.84 (range $449.22 to $450.18).
Referenced by the price of 1 transaction in Table I.
- F11
Open market sales reported on this line occurred at a weighted average price of $451.20 (range $450.71 to $451.70).
Referenced by the price of 1 transaction in Table I.
- F12
Open market sales reported on this line occurred at a weighted average price of $452.20 (range $451.73 to $452.69).
Referenced by the price of 1 transaction in Table I.
- F13
Open market sales reported on this line occurred at a weighted average price of $453.34 (range $452.91 to $453.70).
Referenced by the price of 1 transaction in Table I.
- F14
Open market sales reported on this line occurred at a weighted average price of $455.22 (range $454.88 to $455.66).
Referenced by the price of 1 transaction in Table I.